PainReform Ltd (NAS:PRFX)
$ 3 -0.37 (-10.98%) Market Cap: 1.77 Mil Enterprise Value: -734,000.00 PE Ratio: 0 PB Ratio: 0 GF Score: 27/100

PainReform Ltd at Dawson James Small Cap Growth Stock Conference (Virtual) Transcript

Oct 21, 2021 / 07:15PM GMT
Release Date Price: $600 (-6.02%)
Jason Kolbert
Dawson James - Analyst

Our next company is PainReform. PainReform is very, very significant. Why? Well, I'll tell you that -- I think Frank can testify to this, I busted my knee about two years ago, and it's no joke. And the surgery and the rehab from the busted knee is no joke. They did send me home with about 60 pills of 30 milligrams OxyContin, and I will tell you that after I finished those, I called my doctor and I said I'm still in some pain, feel kind of crappy, and he gave me a second script.

That sent me down a rabbit hole. And I am a guy that's trained in medicine, and I understand or I thought I understood addiction, but what I learned is that the power and draw of these drugs are so great. There is a euphoric effect beyond pain blocking, where your brain actually gets hit with synthetic serotonin.

You know what the biggest risk is when you stop taking them, well first of all, all the pain that you haven't been feeling comes back, and that's very real, but the serotonin that's naturally made in your brain isn't there, so you go into a deep depression.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot